Hermann Luebbert - 09 Dec 2021 Form 4 Insider Report for Biofrontera Inc. (BFRI)

Role
Executive Chairman, Director
Signature
/s/Erica Monaco, Attorney-in-fact for Hermann Luebbert
Issuer symbol
BFRI
Transactions as of
09 Dec 2021
Transactions value $
$0
Form type
4
Filing time
19 Jan 2022, 20:03:39 UTC
Previous filing
28 Oct 2021
Next filing
26 May 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BFRI Restricted Stock Units Award $0 +113,379 $0.000000 113,379 09 Dec 2021 Common Stock 113,379 Direct F1, F2
transaction BFRI Employee stock option (right to buy) Award $0 +113,379 $0.000000 113,379 09 Dec 2021 Common Stock 113,379 $4.77 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of BFRI common stock.
F2 The restricted stock units vest on June 9, 2022. Each vested restricted stock unit will be settled, at the Company's discretion, in shares, cash or a combination of shares and cash within 60 days of the vesting date.
F3 The option vests in three equal annual installments beginning on December 9, 2022.